Advertisement

Tumor Biology

, Volume 35, Issue 1, pp 239–245 | Cite as

Meta-analysis: glutathione S-transferase T1 null allele is associated with gastric cancer risk

  • Wei Sun
  • Li Yao
  • Benchun Jiang
Research Article
  • 163 Downloads

Abstract

Allelic variant within genes encoding glutathione S-transferase T1 (GSTT1) has been suggested to be a possible risk factor of gastric cancer, but previous studies provide controversial results. This study aimed to assess the effects of GSTT1 polymorphism on gastric cancer by means of meta-analysis. We included published studies on the relationship between GSTT1 null allele and gastric cancer risk after searching electronic databases. A meta-analysis was conducted by calculating the pooled odds ratios (OR) and the 95 % confidence intervals (95 % CI). Forty-two studies with a total of 8,203 gastric cancer cases and 13,866 controls were included into this meta-analysis. When all 42 studies were pooled into this meta-analysis, there was a significant association between the GSTT1 null allele and gastric cancer risk (OR = 1.24, 95 % CI 1.14–1.36, P < 0.00001). Sensitivity analysis by excluding individual studies showed that there was no effect on the pooled OR with 95 % CI. After excluding studies with low quality, there was still a significant association between the GSTT1 null allele and gastric cancer risk (OR = 1.24, 95 % CI 1.13–1.36, P < 0.00001). In the subgroup analysis, there was a significant association between the GSTT1 null allele and gastric cancer risk in both Europeans and Asians. There was no risk of publication bias in this meta-analysis. Our results suggest that GSTT1 null allele is associated with increased risk of gastric cancer.

Keywords

Gastric cancer GSTT1 Polymorphism 

Notes

Acknowledgments

We sincerely expressed our thanks to the authors of the primary studies.

Conflict of interests

None

References

  1. 1.
    Camargo MC, Anderson WF, King JB, Correa P, Thomas CC, Rosenberg PS, et al. Divergent trends for gastric cancer incidence by anatomical subsite in us adults. Gut. 2011;60:1644–9.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Villanueva MT. Combination therapy: update on gastric cancer in East Ssia. Nat Rev Clin Oncol. 2011;8:690.PubMedCrossRefGoogle Scholar
  3. 3.
    Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin—active participant or bystander in gastric carcinogenesis? Nat Rev Cancer. 2006;6:936–46.PubMedCrossRefGoogle Scholar
  4. 4.
    Polk DB, Peek Jr RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010;10:403–14.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R, et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut. 2011;60:1189–95.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011;43:1215–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88.PubMedCrossRefGoogle Scholar
  8. 8.
    Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.PubMedCrossRefGoogle Scholar
  9. 9.
    Ruzzo A, Canestrari E, Maltese P, Pizzagalli F, Graziano F, Santini D, et al. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med. 2007;45:822–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, et al. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007;31:233–6.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Tripathi S, Ghoshal U, Ghoshal UC, Mittal B, Krishnani N, Chourasia D, et al. Gastric carcinogenesis: possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 2008;43:431–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Al-Moundhri MS, Alkindy M, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Habsi H, et al. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab population. J Clin Gastroenterol. 2009;43:152–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in kashmir valley. J Gastrointest Cancer. 2009;40:26–32.PubMedCrossRefGoogle Scholar
  14. 14.
    Masoudi M, Saadat I, Omidvari S, Saadat M. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer. Mol Biol Rep. 2009;36:781–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Moy KA, Yuan JM, Chung FL, Wang XL, Van Den Berg D, Wang R, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms and gastric cancer risk: a prospective study of men in shanghai, china. Int J Cancer. 2009;125:2652–9.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Piao JM, Shin MH, Kweon SS, Kim HN, Choi JS, Bae WK, et al. Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol. 2009;15:5716–21.PubMedCrossRefGoogle Scholar
  17. 17.
    Zendehdel K, Bahmanyar S, McCarthy S, Nyren O, Andersson B, Ye W. Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers. Cancer Causes Control. 2009;20:2031–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Nguyen TV, Janssen MJ, van Oijen MG, Bergevoet SM, te Morsche RH, van Asten H, et al. Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncol Res. 2010;18:349–55.PubMedCrossRefGoogle Scholar
  19. 19.
    Palli D, Polidoro S, D'Errico M, Saieva C, Guarrera S, Calcagnile AS, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25:569–75.PubMedCrossRefGoogle Scholar
  20. 20.
    Yadav DS, Devi TR, Ihsan R, Mishra AK, Kaushal M, Chauhan PS, et al. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the northeast indian population. Genet Test Mol Biomarkers. 2010;14:715–23.PubMedCrossRefGoogle Scholar
  21. 21.
    Luo YP, Chen HC, Khan MA, Chen FZ, Wan XX, Tan B, et al. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility. Tumour Biol. 2011;32:215–22.PubMedCrossRefGoogle Scholar
  22. 22.
    Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Association between genetic polymorphisms related to DNA repair or xenobiotic pathways and gastric premalignant conditions. Anticancer Res. 2011;31:1459–65.PubMedGoogle Scholar
  23. 23.
    Tripathi S, Ghoshal U, Mittal B, Chourasia D, Kumar S, Ghoshal UC. Association between gastric mucosal glutathione-s-transferase activity, glutathione-S-transferase gene polymorphisms and Helicobacter pylori infection in gastric cancer. Indian J Gastroenterol. 2011;30:257–63.PubMedCrossRefGoogle Scholar
  24. 24.
    Yadav D, Chandra R, Saxena R, Agarwal D, Agarwal M, Ghosh T, et al. Glutathione-S-transferase M1 and T1 genes and gastric cancer: a case control study in North Indian population. Gene. 2011;487:166–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Zhang AP, Liu BH, Wang L, Gao Y, Li F, Sun SX. Glutathione S-transferase gene polymorphisms and risk of gastric cancer in a Chinese population. Asian Pac J Cancer Prev. 2011;12:3421–5.PubMedGoogle Scholar
  26. 26.
    Garcia-Gonzalez MA, Quintero E, Bujanda L, Nicolas D, Benito R, Strunk M, et al. Lanas A: relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis. 2012;27:771–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Jing C, Huang ZJ, Duan YQ, Wang PH, Zhang R, Luo KS, et al. Glulathione-S-transferases gene polymorphism in prediction of gastric cancer risk by smoking and Helicobacter pylori infection status. Asian Pac J Cancer Prev. 2012;13:3325–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.CrossRefGoogle Scholar
  29. 29.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRefGoogle Scholar
  30. 30.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  31. 31.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  32. 32.
    Agudo A, Sala N, Pera G, Capella G, Berenguer A, Garcia N, et al. Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2006;15:2427–34.PubMedCrossRefGoogle Scholar
  33. 33.
    Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, et al. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case–control study in an Italian population. BMC Cancer. 2007;7:206.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Cai L, Yu SZ, Zhang ZF. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case–control study. World J Gastroenterol. 2001;7:506–9.PubMedGoogle Scholar
  35. 35.
    Choi SC, Yun KJ, Kim TH, Kim HJ, Park SG, Oh GJ, et al. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett. 2003;195:169–75.PubMedCrossRefGoogle Scholar
  36. 36.
    Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, Silva AE. GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population. World J Gastroenterol. 2004;10:1240–5.PubMedGoogle Scholar
  37. 37.
    Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17:881–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP, et al. Glutathione-S-transferases m1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case–control study of a high-incidence area in Jiangsu province, China. Cancer Lett. 2002;188:95–102.PubMedCrossRefGoogle Scholar
  39. 39.
    Gonzalez A, Ramirez V, Cuenca P, Sierra R. Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility. Rev Biol Trop. 2004;52:591–600.PubMedGoogle Scholar
  40. 40.
    Hong SH, Kim JW, Kim HG, Park IK, Ryoo JW, Lee CH, et al. Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer. J Prev Med Public Health. 2006;39:135–40.PubMedGoogle Scholar
  41. 41.
    Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Bell DA: glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Lan Q, Chow WH, Lissowska J, Hein DW, Buetow K, Engel LS, et al. Glutathione S-transferase genotypes and stomach cancer in a population-based case–control study in Warsaw, Poland. Pharmacogenetics. 2001;11:655–61.PubMedCrossRefGoogle Scholar
  43. 43.
    Martinez C, Martin F, Fernandez JM, Garcia-Martin E, Sastre J, Diaz-Rubio M, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 2006;7:711–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer. 2005;116:972–83.PubMedCrossRefGoogle Scholar
  45. 45.
    Nan HM, Park JW, Song YJ, Yun HY, Park JS, Hyun T, et al. Kimchi and soybean pastes are risk factors of gastric cancer. World J Gastroenterol. 2005;11:3175–81.PubMedGoogle Scholar
  46. 46.
    Nan HM, Song YJ, Yun HY, Park JS, Kim H. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol. 2005;11:3834–41.PubMedGoogle Scholar
  47. 47.
    Palli D, Saieva C, Gemma S, Masala G, Gomez-Miguel MJ, Luzzi I, et al. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk Italian population. Int J Cancer. 2005;115:284–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Roth MJ, Abnet CC, Johnson LL, Mark SD, Dong ZW, Taylor PR, et al. Polymorphic variation of cyp1a1 is associated with the risk of gastric cardia cancer: a prospective case–cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes Control. 2004;15:1077–83.PubMedCrossRefGoogle Scholar
  49. 49.
    Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169:21–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Setiawan VW, Zhang ZF, Yu GP, Li YL, Lu ML, Tsai CJ, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case–control study in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2000;9:73–80.PubMedGoogle Scholar
  51. 51.
    Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, et al. Gstp1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control. 2001;12:673–81.PubMedCrossRefGoogle Scholar
  52. 52.
    Tamer L, Ates NA, Ates C, Ercan B, Elipek T, Yildirim H, et al. Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct. 2005;23:267–72.PubMedCrossRefGoogle Scholar
  53. 53.
    Torres MM, Acosta CP, Sicard DM. Groot de Restrepo H: Genetic susceptibility and risk of gastric cancer in a human population of Cauca, Colombia. Biomedica. 2004;24:153–62.PubMedGoogle Scholar
  54. 54.
    Wu MS, Chen CJ, Lin MT, Wang HP, Shun CT, Sheu JC, et al. Genetic polymorphisms of cytochrome P450 2e1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis. 2002;17:338–43.PubMedCrossRefGoogle Scholar
  55. 55.
    Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482:21–6.PubMedCrossRefGoogle Scholar
  56. 56.
    Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011;43:138–51.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of General Surgery, Affiliated Shengjing HospitalChina Medical UniversityShenyangChina
  2. 2.Department of Nephrology, The First Affiliated HospitalChina Medical UniversityShenyangChina

Personalised recommendations